Authors


Thomas E. Keane, MB, ChB, FRCSI

Latest:

Preliminary Treatment Considerations Among Men With Newly Diagnosed Prostate Cancer

In a survey of local-stage prostate cancer patients, preference for prostatectomy was influenced by perceptions of its efficacy and personal burden versus nonsurgical options.


Brian E. Dixon, MPA, PhD, FHIMSS

Latest:

Getting From Here to There: Health IT Needs for Population Health

Aligning health information technology with population health requires organizations to think differently about data needs, exchange partners, and how to leverage both for evidence-based action.


Ronald E. Inge, DDS

Latest:

Case Study of Linking Dental and Medical Healthcare Records

An n - 1 deterministic linkage strategy was used successfully to merge dental and medical data from a healthcare plan and a dental insurance carrier.


Ted Okon, MBA

Latest:

Addressing Cancer Health Disparities in a Multilateral Collaboration in an Independent Community Cancer Clinic: Translating Words Into Action

No One Left Behind, a program to provide financial assistance and access to cancer care at Carolina Blood and Cancer Care Associates in South Carolina, will be discussed during a session of the Community Oncology Alliance 2022 Community Oncology Conference.


Christine Nguyen, MD, MS

Latest:

Opportunities to Improve the Value of Outpatient Surgical Care

Outpatient surgeries in the United States account for roughly 7% of annual healthcare expenditures. To exploit substantial opportunities to improve the value of outpatient surgical care, the authors composed an evidence-based care delivery composite for national discussion and pilot testing.



Alan Balch, PhD

Latest:

The Need to Eliminate Barriers to Personalized Medicine

Precision medicine will perhaps establish some of the most important biomedical innovations of our generation. However, for that future to become a reality, we have to create an access and reimbursement environment that is conducive to precision care.




Helen Blumen, MD, MBA

Latest:

The Value of Colonoscopic Colorectal Cancer Screening of Adults Aged 50 to 64

Screening commercially insured individuals for colorectal cancer is a high-value service, costing less per year of life saved than breast or cervical cancer screening.




Isabel Ostrer, AB

Latest:

Comparison of Healthcare Delivery Systems in Low- and High-Income Communities

This large-scale, national study shows geographic variation in provider supply and hospital access for low- and high-income communities following the Affordable Care Act.


Katie L. Miller, PharmD, BCPS

Latest:

Common Elements in Opioid Use Disorder Guidelines for Buprenorphine Prescribing

This article presents a synthesis of opioid use disorder guidelines and a framework to link them to claims data and recognize higher-quality practice, monitor outcomes, and individualize intervention.


Charles Foreman, MD

Latest:

Prioritized Post-Discharge Telephonic Outreach Reduces Hospital Readmissions for Select High-Risk Patients

A randomized control study that analyzes the impact of a postdischarge prioritization case management strategy on readmissions for select high-risk patients that are commercially insured.








David M. Simon, PhD

Latest:

Medical Utilization Surrounding Initial Opioid-Related Diagnoses by Coding Method

Medical utilization profiles of commercially insured members with opioid-related disorders differ depending on the code used to document the initial diagnosis in administrative claims.


Stephen Zuckerman, PhD

Latest:

Did Medicare Advantage Payment Cuts Affect Beneficiary Access and Affordability?

The Affordable Care Act’s reductions to Medicare Advantage plan payments were not significantly associated with healthcare access or affordability for enrollees.


Marnie Bertolet, PhD

Latest:

Opportunity Costs of Ambulatory Medical Care in the United States

An analysis of the opportunity cost associated with ambulatory medical care in the United States demonstrates substantial time costs for individuals and society.


Tammy G. Curtice, PharmD, MBA, MS

Latest:

Real-World Outcomes Among Patients With Early Rapidly Progressive Rheumatoid Arthritis

This study suggests that lower healthcare resource use and achieving low disease activity are associated with first-line abatacept compared with a first-line tumor necrosis factor-α inhibitor for patients with early rapidly progressive rheumatoid arthritis.


Theodore R. Levin, MD

Latest:

Automated Phone and Mail Population Outreach to Promote Colorectal Cancer Screening

Automated phone and mail population outreach resulted in an almost 4-fold increase in the rate of screening for colorectal cancer even without an office visit.



Rochelle Henderson, PhD, MPA

Latest:

Prescription Rebate Guarantees: Employer Insights

This study examined employers’ understanding of rebate guarantees, dependency upon rebate dollars, and the role that pharmaceutical rebates or employer benefits consultants play in their pharmacy benefits manager selection.



AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo